Drug X-Excite
 |
Erectile dysfunction is a physical condition that affects 10% of men worldwide. The current treatment is the use of drugs that prevent the enzyme 5-phosphodiesterase. Most notable products of this class are Sildenafil, Tadalafil, and Vardenafil, collectively generate over $3 billion annually. All of them carry a considerable side effects due to gasteric and colonic absorption, these include acidoses(gas build up), stol run, and many more. New formulation of these products are developed by us which bypassess all the gasterointestinal side effects, making the drug far more patient friendly and desirable. |
Drug Nico-Z
 |
Addiction to alcohol, tobacco and controlled substances are a major social and health care problem. More than $10 Billion is spent on addiction and addictive products. A never ending growing market. From developing to developed countries, we all face a mountain of social and economic problem. The world is seeking a solution to curb the growth of this industry. We are on the forefront of this issue by bringing new technology to curb the addiction and its growth through society |
Drug T-Slim
 |
Obesity is a big problem. It is estimated that 20% of American to be obese and another 40% are overweight. Beside the exercise, many different food formulation, herbal products and pharmaceutical products are being used to help reduce the appetite, and weight. While the anti-obesity market for products and process are estimated at $5 billion, very little success has been reported. Most people going through the severe forms of exercise and diet, etc, they regain their weight within few months of stopping their diet program The vicious cycle of loose and gain has tired most people. It is highly desirable to have a system that once the body has lost considerable weight, it can stay lean for long time. New drugs are developed which will exactly do that. Once a person gone through the execise and diet and lost weight, by using the drug, he/she may be able to manage to maintain the weght loss as the drug fight strongly against the appetite. |
LATEST MEDICAL NEWS
| Economy Continues To Impact Finances Of Health Companies |
|
Despite a sluggish year, health care investors can look forward to growing emerging markets and a possible change in the U.S. political climate, Forbes reports. "Health care has not had a banner year in 2010 as the sector's stocks have underperformed the market on account of reform in the United States and financial problems in Europe...
|
| Orexigen® Therapeutics Announces Publication Of COR-I Phase 3 Study Of Contrave In Lancet |
|
Orexigen® Therapeutics, Inc. (Nasdaq: OREX) announced that results from its COR-I trial of Contrave® were published online in the journal Lancet. COR-I was the largest of the four, 56-week, Phase 3 trials supporting the New Drug Application for Contrave, currently under review by the U.S. Food and Drug Administration...
|
•Sublingual Drug (X-Excite)
•Rapid onset of action (approx. 5 min and lasting 4 hours), reaching blood within 2 minutes
•No stomach or guts exposure, no gastrointestinal side effects (acidosis, stomach gas build-up, diarrheal)
•Affordable, lower cost.
•Sublingual Drug (Nico-Z)
•Anti addiction product
•Rapid blood absorbtion
•Rapid action against addiction
•Patient friendly and economical
•Sublingual Drug (T-Slim)
•Needle free, easily administered, minimal requirement
•Over the Counter (reduced need for prescriptions)
•Economical, mass distribution, highly affordable